GOP lawmakers eye restrictions on Chinese trial data; Inside Moderna’s unlikely comeback; Italy’s $10 billion pharma family ...

From a 29-state action to individual and school-district claims, the lawsuits that target Instagram and Facebook — plus the product changes and penalties at stake.

Experts say there’s a myriad of factors behind the recent decrease in drug prices, and not all savings will be passed onto ...

A federal law, passed in 2024, bans imports of Russian uranium by 2028, increasing pressure to develop domestic fuel supplies ...

The Food and Drug Administration granted accelerated approval to Zenbexus, or iberdomide, in combination with daratumumab and ...

Lucid Group announced that Eric Muller has joined the agency as CEO on Wednesday morning. The U.K.-based parent company of ...

By one estimate, up to 86% of clinical trials don’t meet their recruitment targets during the trial time frame.

Moderna and Merck’s personalized mRNA cancer vaccine just cleared a huge hurdle. In the first positive Phase 3 trial for an ...

Stephen Farquhar is taking over as CEO of PHM, effective immediately, according to an internal email obtained by MM+M.

Trump’s “America First” proposal for drug reviews; Childhood vaccination coverage sits well below critical threshold; Cialis ...

AbbVie’s Skyrizi maintained its advertising momentum across linear and streaming TV, while BlueChew generated nearly 400 ...

Vertex Pharmaceuticals’ Casgevy, known generically as exagamglogene autotemcel, is the first CRISPR/Cas9 gene-editing therapy ...